francesca lovat
francesca lovat
Bilinmeyen bağlantı
osumc.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
M Fabbri, A Paone, F Calore, R Galli, E Gaudio, R Santhanam, F Lovat, ...
Proceedings of the National Academy of Sciences 109 (31), E2110-E2116, 2012
10782012
EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
M Garofalo, G Romano, G Di Leva, G Nuovo, YJ Jeon, A Ngankeu, J Sun, ...
Nature medicine 18 (1), 74-82, 2012
4032012
Modulation of mismatch repair and genomic stability by miR-155
N Valeri, P Gasparini, M Fabbri, C Braconi, A Veronese, F Lovat, B Adair, ...
Proceedings of the National Academy of Sciences 107 (15), 6982-6987, 2010
3712010
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
N Valeri, P Gasparini, C Braconi, A Paone, F Lovat, M Fabbri, KM Sumani, ...
Proceedings of the National Academy of Sciences 107 (49), 21098-21103, 2010
3392010
miRNA signatures associate with pathogenesis and progression of osteosarcoma
KB Jones, Z Salah, S Del Mare, M Galasso, E Gaudio, GJ Nuovo, F Lovat, ...
Cancer research 72 (7), 1865-1877, 2012
3352012
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer
N Valeri, C Braconi, P Gasparini, C Murgia, A Lampis, V Paulus-Hock, ...
Cancer cell 25 (4), 469-483, 2014
2452014
Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding
B Belletti, JS Vaidya, S D'Andrea, F Entschladen, M Roncadin, F Lovat, ...
Clinical Cancer Research 14 (5), 1325-1332, 2008
2252008
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
M Acunzo, R Visone, G Romano, A Veronese, F Lovat, D Palmieri, ...
Oncogene 31 (5), 634-642, 2012
2042012
MicroRNAs in the pathogenesis of cancer
F Lovat, N Valeri, CM Croce
Seminars in oncology 38 (6), 724-733, 2011
1972011
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
A Vecchione, B Belletti, F Lovat, S Volinia, G Chiappetta, S Giglio, ...
Proceedings of the National Academy of Sciences 110 (24), 9845-9850, 2013
1742013
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential
B Belletti, MS Nicoloso, M Schiappacassi, S Berton, F Lovat, K Wolf, ...
Molecular biology of the cell 19 (5), 2003-2013, 2008
1562008
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation
P Gasparini, F Lovat, M Fassan, L Casadei, L Cascione, NK Jacob, ...
Proceedings of the National Academy of Sciences 111 (12), 4536-4541, 2014
1502014
Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer
L Cascione, P Gasparini, F Lovat, S Carasi, A Pulvirenti, A Ferro, H Alder, ...
PloS one 8 (2), e55910, 2013
1502013
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
P Gasparini, L Cascione, M Fassan, F Lovat, G Guler, S Balci, C Irkkan, ...
Oncotarget 5 (5), 1174, 2014
1332014
p27kip1 functional regulation in human cancer: a potential target for therapeutic designs
B Belletti, MS Nicoloso, M Schiappacassi, E Chimienti, S Berton, F Lovat, ...
Current medicinal chemistry 12 (14), 1589-1605, 2005
1072005
The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt-and mitogen-activated protein kinase-dependent activation of paxillin
D Metalli, F Lovat, F Tripodi, M Genua, SQ Xu, M Spinelli, L Alberghina, ...
The American journal of pathology 176 (6), 2997-3006, 2010
1032010
Lung cancer exosomes as drivers of epithelial mesenchymal transition
MA Rahman, JF Barger, F Lovat, M Gao, GA Otterson, P Nana-Sinkam
Oncotarget 7 (34), 54852, 2016
852016
ERK activation globally downregulates miRNAs through phosphorylating exportin-5
HL Sun, R Cui, JK Zhou, K Teng, YH Hsiao, K Nakanishi, M Fassan, Z Luo, ...
Cancer cell 30 (5), 723-736, 2016
762016
Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options
P Gasparini, M Fassan, L Cascione, G Guler, S Balci, C Irkkan, C Paisie, ...
PLoS One 9 (2), e88525, 2014
752014
B-cell malignancies in microRNA Eμ-miR-17∼ 92 transgenic mice
SK Sandhu, M Fassan, S Volinia, F Lovat, V Balatti, Y Pekarsky, ...
Proceedings of the National Academy of Sciences 110 (45), 18208-18213, 2013
752013
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20